Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
Portfolio Pulse from Avi Kapoor
Stocks to watch include Abbott Laboratories, Intra-Cellular Therapies, U.S. Bancorp, Ontrak, and The Travelers Companies, with a focus on upcoming earnings reports and financial results. Abbott Laboratories is expected to report earnings with a positive after-hours trading response, while Intra-Cellular Therapies announced a $500 million public offering, leading to a stock price decline. U.S. Bancorp's earnings expectations are set, with a slight decrease in after-hours trading. Ontrak reported worse-than-expected financial results, causing a significant drop in its stock price. The Travelers Companies is anticipated to post earnings, with a slight increase in after-hours trading.
April 17, 2024 | 6:06 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Abbott Laboratories is expected to report quarterly earnings at 95 cents per share on revenue of $9.88 billion, with shares up 1% in after-hours.
Positive after-hours trading movement suggests investor optimism ahead of the earnings report, potentially leading to a short-term price increase.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
The Travelers Companies is anticipated to post earnings at $4.90 per share, with shares up 0.8% in after-hours trading.
A positive after-hours trading response indicates investor optimism, potentially leading to a short-term increase in stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
NEUTRAL IMPACT
U.S. Bancorp is expected to post earnings at 88 cents per share on revenue of $6.72 billion, with a slight decrease in after-hours trading.
The slight decrease in after-hours trading suggests a cautious investor sentiment, potentially leading to a neutral short-term impact.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 75
NEGATIVE IMPACT
Intra-Cellular Therapies announced a $500 million public offering, leading to a 1.3% decline in after-hours trading.
The announcement of a significant public offering often leads to concerns about dilution, causing a short-term negative impact on stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
Ontrak reported worse-than-expected Q4 results, with a 14.2% drop in after-hours trading.
Significantly missing earnings and sales estimates typically results in a sharp decline in stock price, as seen with Ontrak.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 95